Skip to main content

Day: July 14, 2021

Chief Executive Officer Ian Parker’s Annual Letter to Shareholders

Healixa Inc. (f.k.a. Emerald Organic Products Inc.) today releases an open letter to shareholders from the Company’s CEO Holbrook, New York, July 14, 2021 (GLOBE NEWSWIRE) — Healixa, Inc. (OTC Pink: EMOR) (f.k.a. Emerald Organic Products Inc.) (“Healixa”, or the “Company”), a people-first digital organization that humanizes care by deploying simplified solutions for complex global challenges, today offers an open letter to shareholders from Chief Executive Officer Ian Parker which reports on the Company’s 2021 year-to-date progress and shares his outlook for the balance of 2021. Shareholders, Healixa has created a staggering portfolio of “healing technologies”.  We have yet to unveil the full breath of our portfolio, but this letter will serve as a prelude to many of the exciting technologies to come. Collectively these ethically...

Continue reading

Landsbankinn hf.: Financial results for the first half of 2021 to be published 22 July 2021

Landsbankinn will publish the financial results for the first half of 2021 on Thursday, 22 July 2021. The following day, 23 July at 10:00 local time, the bank will host an investor call in English covering the main results. Please register to the call by emailing ir@landsbankinn.is. For further information contact: Hanna Kristín Thoroddsen, Investor Relations, ir@landsbankinn.is

Continue reading

INMUNE BIO, INC. ANNOUNCES $40 MILLION REGISTERED DIRECT OFFERING

Boca Raton, FL., July 14, 2021 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune Bio”), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, today announced that it has entered into a definitive agreement with one healthcare focused institutional investor and one family office for the purchase and sale of 1,818,182 shares of its common stock at a price of $22.00 per share for gross proceeds of approximately $40 million in a registered direct offering. The closing of the offering is expected to occur on or about July 16, 2021, subject to the satisfaction of customary closing conditions. A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering. INmune Bio intends to use the net proceeds from this...

Continue reading

Gevo to Report Second Quarter 2021 Financial Results on August 12, 2021

ENGLEWOOD, Colo., July 14, 2021 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) announced today that it will host a conference call on Thursday, August 12, 2021 at 4:30 p.m. EDT (2:30 p.m. MDT) to report its financial results for the second quarter ended June 30, 2021 and provide an update on recent corporate highlights. To participate in the conference call, please dial 1 (833) 729-4776 (inside the U.S.) or 1 (830) 213-7701 (outside the U.S.) and reference the access code 2267135# or through the event weblink: https://edge.media-server.com/mmc/p/8w4ypxhw A replay of the call and webcast will be available two hours after the conference call ends on August 12, 2021. To access the replay, please dial 1 (855) 859-2056 (inside the U.S.) or 1 (404) 537-3406 (outside the U.S.) and reference the access code 2267135#. The archived webcast...

Continue reading

EnWave Signs Royalty-Bearing License with Second New Zealand Cannabis Company and Completes GMP REV™ Machine Sale

VANCOUVER, British Columbia, July 14, 2021 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announces that it has signed a non-exclusive royalty-bearing commercial license (the “License”) with a New Zealand cannabis company, Medical Kiwi Limited (“Medical Kiwi”). The License grants Medical Kiwi the right to use EnWave’s patented Radiant Energy Vacuum (“REV™”) technology for the production of cannabis products in New Zealand. Medical Kiwi has purchased a 10kW REV™ machine that will be used to dry cannabis flower for use in medicinal products. This REV™ machine will be built to the standard of Good Manufacturing Practices (“GMP”) which will enable Medical Kiwi to export medicinal cannabis products to Europe and around the world. EnWave’s REV™ technology offers a fast, gentle drying method...

Continue reading

Altair International Completes a Soil Sampling Program at Its Stonewall Lithium Project Near Clayton Valley

PITTSBURGH, July 14, 2021 (GLOBE NEWSWIRE) — Altair International Corp. (the “Company” or “Altair”) (OTCQB: ATAO) is pleased to announce that it has completed a property-wide shallow-depth sampling program at its Stonewall Lithium Project in southwestern Nevada. The completed geochemical surveying program, amounting to roughly 120 samples, represents Altair’s first phase of field work at the Stonewall Lithium property. The samples were collected following a methodical sample grid array which effectively covered the entirety of the three Stonewall claim groups. The Stonewall Lithium Project is comprised of three zones which cover approximately 1,260 acres, located within Nye and Esmeralda Counties. The neighboring valley to the southeast to Clayton Valley, currently the only Lithium producing property in Nevada. The sampling...

Continue reading

CLC Experiencing Stellar Performance of Experimental Strains and Excellent Overall Plant Growth During Record High Temperatures

Picture 1Drone surveillance technology has played a significant role in the Company’s ability to monitor the overall quality of its crop to include enhanced monitoring of hydration levels through advanced thermal imaging technologyVANCOUVER, British Columbia, July 14, 2021 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) is pleased to provide its first operational update pertaining to the 2021 growing season in which the Company is cultivating a large quantity of clones and seedlings outdoors under natural sunlight. In addition to the seven proprietary cannabis strains which comprise the majority of CLC’s plants being grown this year, more than 90 experimental strains are also under observation in the field with an...

Continue reading

NAACP to Present Historic Spingarn Medal to Regenerative Engineering Pioneer Cato T. Laurencin, M.D., Ph.D., at 112th Annual Convention

MIMEDX Applauds Dr. Laurencin on Receiving NAACP’s Highest Honor for His Contributions to Emerging Medical Sciences that Advance Human Healing MARIETTA, Ga., July 14, 2021 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today congratulates Cato T. Laurencin, M.D., Ph.D., Van Dusen Distinguished Endowed Professor at the University of Connecticut, on being awarded the Spingarn Medal, the NAACP’s most prestigious honor. In addition to the academic pursuits for which he is being recognized, Dr. Laurencin serves as a member of the MIMEDX Board of Directors. Honoring his accomplishments in the fields of tissue regeneration, biomaterials science, nanotechnology, and regenerative engineering – a field he founded –...

Continue reading

Advanced Silicon Battery Company Enovix Corporation and Rodgers Silicon Valley Acquisition Corp. Announce Closing of Business Combination; Enovix to trade on Nasdaq under ticker “ENVX” on July 15

Deal marks beginning of race to bring next-generation high-density batteries into commercial-scale production FREMONT, Calif. and WOODSIDE, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”), the leader in the design and manufacture of 3D Silicon™ Lithium-ion batteries, announced today that it has completed its previously announced business combination with Rodgers Silicon Valley Acquisition Corp. (Nasdaq: RSVA, RSVAU, RSVAW) (“RSVAC”), a publicly traded special purpose acquisition company or SPAC. RSVAC’s shareholders approved the combination at a special meeting held on July 12, 2021. The combined company will retain the name Enovix Corporation and is expected to begin trading on the Nasdaq Global Select Market (“Nasdaq”) on July 15, under the new ticker symbol “ENVX” for Enovix common stock and “ENVXW” for...

Continue reading

Prime Upgrades Fleet With ORBCOMM’s Next Generation Refrigerated Monitoring Solution

Ensures the reliability and efficiency of their communications along the cold chain and protection from network obsolescencePrime Inc.ORBCOMM’s next-gen IoT technology ensures the reliability and efficiency of Prime’s communications along the cold chain and protection from network obsolescence.ROCHELLE PARK, N.J., July 14, 2021 (GLOBE NEWSWIRE) — ORBCOMM Inc. (Nasdaq: ORBC), a global provider of Internet of Things (IoT) solutions, today announced that Prime Inc. (Prime), the largest refrigerated fleet in North America, has begun the retrofit of their refrigerated trailers with ORBCOMM’s next generation refrigerated monitoring solution in preparation for the sunsetting of 3G wireless service, which will commence at the end of 2021. An ORBCOMM customer for more than 10 years, Prime is utilizing ORBCOMM’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.